Medicinal Cannabis Funding: NZX-listed Rua Bioscience opened a $2.8m three-for-one renounceable rights offer to build inventory and fund working capital after a major export deal. Care Access via Captive Benefits: Blackwell Captive Solutions partnered with Apta Health to roll out Apta Cash, a guided cash-pay care option for employers in its cannabis-focused captive network. Medical Cannabis in Practice: Ukraine’s health ministry says a female cancer patient in Mykolaiv received medical cannabis-based medication for the first time, via electronic prescription and recorded dispensing. Clinical Safety Signal (Epilepsy): A new study in Epilepsia links frequent cannabis use (at least 20 days/month) with more severe seizures and faster resistance to antiseizure meds in drug-resistant epilepsy patients. Regulatory/Enforcement: Montgomery County (MD) advanced charges against 46 businesses for selling illegal THC products, while Wisconsin lawmakers moved to remove Flock license-plate reader cameras from county parks. Product/Manufacturing Update: Dunbar Pharma confirmed UK specialist prescribers can now access plant-derived dronabinol oral sprays via IPS Pharma. Industry Ownership: Australia’s Tasmanian Botanics is now almost fully Chinese-owned after Yongji Health bought remaining shares.